Next Article in Journal
A Booster with a Genotype-Matched Inactivated Newcastle Disease Virus (NDV) Vaccine Candidate Provides Better Protection against a Virulent Genotype XIII.2 Virus
Next Article in Special Issue
CD4+ T Cell Responses to Toxoplasma gondii Are a Double-Edged Sword
Previous Article in Journal
The Quantification of Spike Proteins in the Inactivated SARS-CoV-2 Vaccines of the Prototype, Delta, and Omicron Variants by LC–MS
 
 
Article

Article Versions Notes

Vaccines 2023, 11(5), 1003; https://doi.org/10.3390/vaccines11051003
Action Date Notes Link
article xml file uploaded 20 May 2023 08:30 CEST Original file -
article xml uploaded. 20 May 2023 08:30 CEST Update -
article pdf uploaded. 20 May 2023 08:30 CEST Version of Record https://www.mdpi.com/2076-393X/11/5/1003/pdf-vor
article html file updated 20 May 2023 08:32 CEST Original file -
article xml file uploaded 22 May 2023 08:00 CEST Update -
article xml uploaded. 22 May 2023 08:00 CEST Update -
article pdf uploaded. 22 May 2023 08:00 CEST Updated version of record https://www.mdpi.com/2076-393X/11/5/1003/pdf-vor
article html file updated 22 May 2023 08:01 CEST Update -
article xml file uploaded 25 May 2023 07:54 CEST Update -
article xml uploaded. 25 May 2023 07:54 CEST Update https://www.mdpi.com/2076-393X/11/5/1003/xml
article pdf uploaded. 25 May 2023 07:54 CEST Updated version of record https://www.mdpi.com/2076-393X/11/5/1003/pdf
article html file updated 25 May 2023 07:55 CEST Update https://www.mdpi.com/2076-393X/11/5/1003/html
Back to TopTop